EU investigation into $130 billion Dow, DuPont deal resumes
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
The Dow logo is seen at the entrance to Dow Chemical headquarters in Midland, Michigan May 14, 2015. REUTERS/Rebecca Cook/File Photo
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
BRUSSELS (Reuters) - Dow Chemical (NYSE: DOW) and DuPont (NYSE: DD) have provided key data allowing European Union antitrust regulators to resume scrutiny of their $130 billion merger, the European Commission said on Wednesday.
The EU competition enforcer stopped its investigation last month after the companies failed to submit crucial information.
"We have received the missing information and the clock has been re-started. The new deadline for the Commission to take a decision is 28 February 2017," a Commission spokesman said in an email.
The Commission is worried the merger to create a giant in crop protection and seeds may reduce competition in these areas as well as certain petrochemicals.
(Reporting by Foo Yun Chee; Editing by Mark Potter)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly (LLY) to Acquire CoLucid Pharmaceuticals (CLCD) for $960M
- UPDATE: Federal Judge to Block Anthem (ANTM), Cigna Corp. (CI) Merger - NYP
- Morgan Stanley, Citi plan Brexit job moves: sources
Create E-mail Alert Related CategoriesLitigation, Mergers and Acquisitions, Reuters
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!